Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity.

Source:http://linkedlifedata.com/resource/pubmed/id/1846213

Download in:

View as

General Info

PMID
1846213